The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Valneva’s single-dose chikungunya vaccine for use ...

UK MHRA grants marketing authorization to Valneva’s chikungunya vaccine, Ixchiq: Saint Herblain, France Thursday, February 6, 2025, 12:00 Hrs [IST] Valneva SE, a specialty vacci ...

GBS, a neurological condition triggered by an overactive immune system often after viral or bacterial infections, has been ...

A second type of bird flu H5N1 has been detected in US cattle Some experts believe the risk for humans is low Infections have also been detected outside the US, in the United Kingdom European authorit ...

Another child exhibiting symptoms of Guillain-Barre Syndrome (GBS) has been admitted to a hospital in Ranchi, bringing the total number of suspected cases in Jharkhand to three.

NTDs, a group of 21 debilitating infectious diseases, affect over 1 billion people globally, causing significant morbidity, disability, and death. These diseases, including visceral leishmaniasis (VL) ...

The closure of USAID could deal a body blow to planned projects, especially those which are fully dependent on the US agency, given the weak financial position of Congress-led Telangana government ...

H.C. Wainwright reaffirmed its Buy rating and $18.00 price target for Valneva (EPA:VLS) SE (NASDAQ:VALN) shares, following the recent approval of the company's Ixchiq vaccine in the United Kingdom ...

A second type of the virus, D1.1, has been detected in dairy cattle in Nevada, US. A second type of bird flu H5N1 detected in ...

In a report released on February 5, Justine Telliez from Kepler Capital maintained a Buy rating on Valneva (0OB3 – Research Report), with a ...

The company expects 2025 adjusted profit to be in the range of $8.15 to $8.35 per share, compared with the average of ...

Flies circulating in hospital wards may pose a threat to vulnerable patients by spreading bacteria that are resistant to ...